Literature DB >> 11194311

Social costs of untreated opioid dependence.

R Wall1, J Rehm, B Fischer, B Brands, L Gliksman, J Stewart, W Medved, J Blake.   

Abstract

Using cost-of-illness methodology applied to a comprehensive survey of 114 daily opiate users not currently in or seeking treatment for their addiction, we estimated the 1996 social costs of untreated opioid dependence in Toronto (Ontario, Canada). The survey collected data on social and demographic characteristics, drug use history, physical and mental health status, the use of health care and substance treatment services, drug use modality and sex-related risks of infectious diseases, sources of income, as well as criminality and involvement with the law enforcement system. The annual social cost generated by this sample, calculated at Canadian $5.086 million, is explained mostly by crime victimization (44.6%) and law enforcement (42.4%), followed by productivity losses (7.0%) and the utilization of health care (6.1%). Applying the $13,100 cost to the estimated 8,000 to 13,000 users and 2.456 million residents living in Toronto yields a range of social cost between $43 and $69 per capita.

Entities:  

Mesh:

Year:  2000        PMID: 11194311      PMCID: PMC3456775          DOI: 10.1007/bf02344032

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  33 in total

1.  The valuation of productivity costs due to premature mortality: a comparison of the human-capital and friction-cost methods for schizophrenia.

Authors:  R Goeree; B J O'Brien; G Blackhouse; K Agro; P Goering
Journal:  Can J Psychiatry       Date:  1999-06       Impact factor: 4.356

Review 2.  A time for everything: changing attitudes and approaches to reducing substance abuse.

Authors:  J S Millar
Journal:  CMAJ       Date:  1998-09-08       Impact factor: 8.262

3.  Validity of self-reported data, scientific methods and drug policy.

Authors:  D C Des Jarlais
Journal:  Drug Alcohol Depend       Date:  1998-08-01       Impact factor: 4.492

4.  Reliability and validity of self-report: on the importance of considering context.

Authors:  E Finch; J Strang
Journal:  Drug Alcohol Depend       Date:  1998-08-01       Impact factor: 4.492

Review 5.  Self-report among injecting drug users: a review.

Authors:  S Darke
Journal:  Drug Alcohol Depend       Date:  1998-08-01       Impact factor: 4.492

6.  The news on the street: prescription drugs on the black market.

Authors:  B Goldman
Journal:  CMAJ       Date:  1998-07-28       Impact factor: 8.262

7.  Economic burden of drug dependency. Social costs incurred by drug users at intake to the National Treatment Outcome Research Study.

Authors:  A Healey; M Knapp; J Astin; M Gossop; J Marsden; D Stewart; P Lehmann; C Godfrey
Journal:  Br J Psychiatry       Date:  1998-08       Impact factor: 9.319

Review 8.  Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction.

Authors: 
Journal:  JAMA       Date:  1998-12-09       Impact factor: 56.272

Review 9.  Review of integrated mental health and substance abuse treatment for patients with dual disorders.

Authors:  R E Drake; C Mercer-McFadden; K T Mueser; G J McHugo; G R Bond
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

10.  The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992.

Authors:  E Single; L Robson; X Xie; J Rehm
Journal:  Addiction       Date:  1998-07       Impact factor: 6.526

View more
  25 in total

1.  Displacement of Canada's largest public illicit drug market in response to a police crackdown.

Authors:  Evan Wood; Patricia M Spittal; Will Small; Thomas Kerr; Kathy Li; Robert S Hogg; Mark W Tyndall; Julio S G Montaner; Martin T Schechter
Journal:  CMAJ       Date:  2004-05-11       Impact factor: 8.262

2.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

3.  Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?

Authors:  Susan L Ettner; David Huang; Elizabeth Evans; Danielle Rose Ash; Mary Hardy; Mickel Jourabchi; Yih-Ing Hser
Journal:  Health Serv Res       Date:  2006-02       Impact factor: 3.402

Review 4.  Using administrative data for longitudinal substance abuse research.

Authors:  Elizabeth Evans; Christine E Grella; Debra A Murphy; Yih-Ing Hser
Journal:  J Behav Health Serv Res       Date:  2008-08-05       Impact factor: 1.505

Review 5.  Misuse of and dependence on opioids: study of chronic pain patients.

Authors:  Meldon Kahan; Anita Srivastava; Lynn Wilson; Douglas Gourlay; Deana Midmer
Journal:  Can Fam Physician       Date:  2006-09       Impact factor: 3.275

6.  Canadian trends in opioid-related mortality and disability from opioid use disorder from 1990 to 2014 through the lens of the Global Burden of Disease Study.

Authors:  Heather M Orpana; Justin J Lang; Maulik Baxi; Jessica Halverson; Nicole Kozloff; Leah Cahill; Samiah Alam; Scott Patten; Howard Morrison
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-06       Impact factor: 3.240

7.  Methadone use among HIV-positive injection drug users in a Canadian setting.

Authors:  Tyler Pettes; Evan Wood; Silvia Guillemi; Calvin Lai; Julio Montaner; Thomas Kerr
Journal:  J Subst Abuse Treat       Date:  2010-07-03

8.  The costs of crime associated with stimulant use in a Canadian setting.

Authors:  Benjamin Enns; Emanuel Krebs; Kora DeBeck; Kanna Hayashi; M-J Milloy; Lindsey Richardson; Evan Wood; Bohdan Nosyk
Journal:  Drug Alcohol Depend       Date:  2017-09-14       Impact factor: 4.492

9.  Nonfatal overdose among a cohort of street-involved youth.

Authors:  Daniel Werb; Thomas Kerr; Calvin Lai; Julio Montaner; Evan Wood
Journal:  J Adolesc Health       Date:  2007-12-26       Impact factor: 5.012

10.  Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users.

Authors:  Kelly E Dunn; Anthony Defulio; Jeffrey J Everly; Wendy D Donlin; Will M Aklin; Paul A Nuzzo; Jeannie-Marie S Leoutsakos; Annie Umbricht; Michael Fingerhood; George E Bigelow; Kenneth Silverman
Journal:  Exp Clin Psychopharmacol       Date:  2012-12-03       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.